Heterogeneity of outcome with single-agent carfilzomib: all relapsed/refractory myelomas are not created equal

被引：2
|
作者：
Usmani, S. Z. [1 ]
Hoering, A. [2 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Canc Res & Biostat, Seattle, WA USA
来源：
LEUKEMIA | 2013年 / 27卷 / 12期
关键词：
TOTAL THERAPY 3; MULTIPLE-MYELOMA; BORTEZOMIB; DELETION;
D O I：
10.1038/leu.2013.161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2269 / 2271
页数：3
相关论文
共 50 条
  • [31] A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use
    Jonsson, F.
    Ou, Y.
    Claret, L.
    Siegel, D.
    Jagannath, S.
    Vij, R.
    Badros, A.
    Aggarwal, S.
    Bruno, R.
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (12): : 711 - 719
  • [32] A TUMOR GROWTH INHIBITION MODEL BASED ON M-PROTEIN LEVELS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FOLLOWING SINGLE-AGENT CARFILZOMIB USE
    Jonsson, F.
    Siegel, D.
    Jagannath, S.
    Vij, R.
    Badros, A.
    Ou, Y.
    Claret, L.
    Kavalerchik, E.
    Bruno, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S75 - S75
  • [33] The Speed of Response to Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma: An Exploratory Analysis of Results From 2 Multicenter Phase 2 Clinical Trials
    Wang, Luhua
    Siegel, David S.
    Jakubowiak, Andrzej J.
    Wong, Alvin F.
    Dixon, Sandra
    Renau, Thomas E.
    Vij, Ravi
    [J]. BLOOD, 2011, 118 (21) : 1698 - 1698
  • [34] SALVAGE TREATMENT WITH SINGLE-AGENT BENDAMUSTINE FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: AN ITALIAN MONOCENTRIC EXPERIENCE
    Ricciuti, G.
    Finolezzi, E.
    Falorio, S.
    Luciani, S.
    Ranucci, E.
    Angrilli, F.
    [J]. HAEMATOLOGICA, 2014, 99 : 677 - 678
  • [35] Single-agent daratumumab for refractory POEMS syndrome
    Tiew, Han Wei
    Sampath, Venkata Sreekanth
    Gallardo, Christian Aledia
    Christopher, Dheepa
    Chan, Stephrene Seok Wei
    Wong, Shiun Woei
    Tso, Allison Ching Yee
    Lee, Lian King
    Fan, Bingwen Eugene
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E189 - E191
  • [36] An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib
    Vij, Ravi
    Siegel, David S.
    Jagannath, Sundar
    Jakubowiak, Andrzej J.
    Stewart, Alexander Keith
    McDonagh, Kevin
    Bahlis, Nizar
    Belch, Andrew
    Kunkel, Lori A.
    Wear, Sandra
    Wong, Alvin F.
    Orlowski, Robert Z.
    Wang, Michael
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (06) : 739 - 748
  • [37] Outcome studies - Are all antihypertensive drugs created equal?
    Messerli, FH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) : 1652 - 1653
  • [38] Unfavorable Cytogenetic Characteristics Do Not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003 (A1) Study
    Jakubowiak, Andrzej J.
    Siegel, David S.
    Singhal, Seema
    Martin, Thomas
    Lonial, Sagar
    Kukreti, Vishal
    Bahlis, Nizar
    Chanan-Khan, Asher Alban
    Alsina, Melissa
    Somlo, George
    Buadi, Francis K.
    Reu, Frederic J.
    Song, Kevin W.
    Kunkel, Lori
    Wear, Sandra M.
    Wong, Alvin F.
    Orlowski, Robert Z.
    Stewart, A. Keith
    Jagannath, Sundar
    Wang, Luhua
    [J]. BLOOD, 2011, 118 (21) : 818 - 819
  • [39] Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study
    A J Jakubowiak
    D S Siegel
    T Martin
    M Wang
    R Vij
    S Lonial
    S Trudel
    V Kukreti
    N Bahlis
    M Alsina
    A Chanan-Khan
    F Buadi
    F J Reu
    G Somlo
    J Zonder
    K Song
    A K Stewart
    E Stadtmauer
    B L Harrison
    A F Wong
    R Z Orlowski
    S Jagannath
    [J]. Leukemia, 2013, 27 : 2351 - 2356
  • [40] Dacarbazine as Single-Agent Therapy for Relapsed Lymphoma in Dogs
    Griessmayr, P. C.
    Payne, S. E.
    Winter, J. E.
    Barber, L. G.
    Shofer, F. S.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (06): : 1227 - 1231
12345